Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
22.07.2025 23:02:45
|
Quest Diagnostics Raises 2025 Guidance
Diagnostic testing and information services provider Quest Diagnostics (NYSE:DGX) reported fiscal 2025 second-quarter results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 revenue hit $2.76 billion and adjusted earnings per share (EPS) came in at $2.62. These results reflect improvements across sales, margins, and operating income, with management raising its outlook for both revenue and adjusted diluted EPS. The quarter showed a strong contribution from acquisitions, balanced by modest organic volume growth and slight pressure on revenue per requisition.Source: Quest Diagnostics. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year. pp = percentage points. Continue readingWeiter zum vollständigen Artikel bei MotleyFool